Peanut Allergy and Component-Resolved Diagnostics Possibilities—What Are the Benefits?
Nutrients · 2023
DOI: 10.3390/nu15245132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Joanna Połomska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department and Clinic of Paediatrics, Allergology and Cardiology, Wroclaw Medical University, ul. Chałubińskiego 2a, 50-368 Wrocław, Poland. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Anaphylaxis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. It is estimated to affect around 1–2% of the population in several developed countries. Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. It is a technique that enables the analysis of specific IgE antibodies against tightly defined molecules (components) that constitute the allergen. Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. It also aids in predicting the course of the allergy and enables the development of personalized immunotherapy plans; however, the full application of it for these purposes still requires more precise studies. In this paper, we present the current knowledge about peanut allergy and component-resolved diagnostics possibilities. We discuss the possibilities of using molecular diagnostics in the diagnosis of peanut allergy. We focus on examining and predicting the development of peanut allergy, including the risk of anaphylaxis, and describe the latest data related to desensitization to peanuts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department and Clinic of Paediatrics, Allergology and Cardiology, Wroclaw Medical University, ul. Chałubińskiego 2a, 50-368 Wrocław, Poland.
- Clinical Department of Paediatrics, Specialist Hospital No. 2, Bytom, Silesian Medical University, 40-055 Katowice, Poland.
ORCID-Profile: Barbara Sozańska
Zitieren
APA
Połomska, J., Dydak, P., Sozańska, B., & Sikorska-Szaflik, H. (2023). Peanut Allergy and Component-Resolved Diagnostics Possibilities—What Are the Benefits?. Nutrients. https://doi.org/10.3390/nu15245132
Vancouver
Połomska J, Dydak P, Sozańska B, Sikorska-Szaflik H. Peanut Allergy and Component-Resolved Diagnostics Possibilities—What Are the Benefits?. Nutrients. 2023. doi:10.3390/nu15245132
BibTeX
@article{Poomska2023,
author = {Połomska, Joanna and Dydak, Paulina and Sozańska, Barbara and Sikorska-Szaflik, Hanna},
title = {Peanut Allergy and Component-Resolved Diagnostics Possibilities—What Are the Benefits?},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15245132}
}
EUVIMED